
Solid Biosciences Inc. Common Stock
SLDB
SLDB: Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.
moreShow SLDB Financials
Recent trades of SLDB by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by SLDB's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Followers on SLDB's company Twitter account
Number of mentions of SLDB in WallStreetBets Daily Discussion
Recent insights relating to SLDB
Recent picks made for SLDB stock on CNBC
ETFs with the largest estimated holdings in SLDB
Flights by private jets registered to SLDB